Floatz logo

NEPENTHE

Hypertriglyceridemia

Nemours Children's ClinicSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hypertriglyceridemia cohort.

Asset / SponsorPhaseRating
Saffron
Birjand University of Medical Sciences
Phase 4BB
Amprenavir
Felizarta, Franco, M.D.
Phase 4BB
Fenofibrate
Abbott
Phase 4BB
(1-BENZYL-3-(ISOBUTYL-(4-NITRO-BENZENESULFONYL)-AMINO)-2-PHOSPHONOOXY-PROPYL)-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER
Felizarta, Franco, M.D.
Phase 4BB
Lipitor
The University of Western Australia
Phase 4BB

View all 27 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →